Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2026-04-08
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst EventDNA — Ginkgo Bioworks Holdings Inc
NYSE · Life Sciences Tools & Services · Life Sciences Tools & Services
$8.21-16.05%Market cap344.60M
- Latest Close
- $8.21
- 30-Day Move
- -16.1%
- Market Cap
- $345M
- Shares Outstanding
- 58,920,000
- P/B Ratio
- 0.99
- ROE
- -61.5%
NYSE:DNALife Sciences Tools & Services / Life Sciences Tools & ServicesDelayed public snapshot
Ginkgo Bioworks Holdings Inc
A read-only Alphactor snapshot forGinkgo Bioworks Holdings Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$8.21
30-Day Move
-16.1%
Market Cap
$345M
Shares Outstanding
58,920,000
P/B Ratio
0.99
ROE
-61.5%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$8.21
-16.1%last 90 delayed daily bars
Market cap$345M
90D High
$11.10
90D Low
$5.37
Avg Volume
1,121,053
What stands out
Gross margin is running at 72.4%, which gives a quick read on operating quality before you open the full model.
Net margin is -183.8%, useful for comparing DNA against peers in Life Sciences Tools & Services.
DNA is down 16.1% over the last 30 trading days shown on this page.
Latest operating income is $-304M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$9.81
Rule of 40
-130.1%
Dark Pool Short %
62.4%
Fundamentals snapshot
Latest Close
$8.21
30-Day Move
-16.1%
Market Cap
$345M
Shares Outstanding
58,920,000
P/B Ratio
0.99
ROE
-61.5%
ROA
-27.9%
Gross Margin
72.4%
Operating Margin
-194.9%
Net Margin
-183.8%
Debt / Equity
0
Current Ratio
4.92
Latest Revenue
$170M
Financial statement snapshot
Revenue
$170M
Gross Profit
$123M
Operating Income
$-304M
Net Income
$-313M
Gross Margin
7239.0%
Net Margin
-18381.0%
Current Ratio
4.92
Debt / Equity
0.00
Valuation snapshot
Fair Value
$9.81
Upside / Downside
+19.5%
Signal
Fairly Valued
Implied Growth
--
EV/Rev
$9.81
Growth Assumption
-10.0%
Discount Rate
10.5%
Terminal Growth
2.0%
Base FCF
--
Valuation spread
Current Price
$8.21
Composite Fair Value
$9.81
EV/Rev
$9.81
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative FCF — company is cash-flow negative. Reverse DCF requires positive cash flows.
Quality snapshot
Altman Z
-7.69
Distress
Piotroski
2
Weak (0-3)
Cash Conversion
0.55x
Rule of 40
-130.1%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $478M | $-2.2B | $-2.1B | $-304M |
| 2023-12-31 | $251M | $-768M | $-893M | $-336M |
| 2024-12-31 | $227M | $-488M | $-547M | $-382M |
| 2025-12-31 | $170M | $-304M | $-313M | $-179M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2025-09-23
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of GrowthPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2025-03-03
Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsightPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2024-12-05
Synthetic Biology Market Forecast: $61.6 Billion by 2029, Growing at 26.1% CAGRPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/globenewswire.ico', homepage_url='https://www.globenewswire.com', logo_url='https://s3.massive.com/public/assets/news/logos/globenewswire.svg', name='GlobeNewswire Inc.')•2024-10-08
Transforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche ResearchAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$4M
Buys
0
Sells
21
Buy Value
$0
Sell Value
$4M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-17 | Coen Steven P. | Sell | 324 | $7.95 |
| 2026-04-16 | Coen Steven P. | M | 156 | $0.00 |
| 2026-04-16 | Coen Steven P. | M | 587 | $0.00 |
| 2026-04-16 | Coen Steven P. | M | 156 | $0.00 |
| 2026-04-16 | Coen Steven P. | M | 587 | $0.00 |
| 2026-04-13 | Coen Steven P. | Sell | 33,171 | $6.41 |
| 2026-04-10 | Coen Steven P. | M | 45,553 | $0.00 |
| 2026-04-10 | Coen Steven P. | M | 28,368 | $0.00 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1,331,411 | 0.03% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | 1,018,359 | 0.02% | 2026-02-28 |
| VANGUARD WORLD FUND-Vanguard U.S. Growth Fund | 465,798 | 0.01% | 2025-11-30 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 465,718 | 0.01% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 401,381 | 0.01% | 2026-01-31 |
| SPDR SERIES TRT-State Street SPDR S&P Kensho New Economies Composite E | 356,032 | 0.01% | 2026-02-28 |
| EXCHANGE TRADED CONCEPTS TRUST-ROBO Global Artificial Intelligence ETF | 349,793 | 0.01% | 2026-02-28 |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 341,988 | 0.01% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Qube Research & Technologies
Filed 2025-05-15
--
--
BlackRock
Filed 2024-05-10
$85M
--
Vanguard Group
Filed 2025-11-07
$36M
+4.2%
Geode Capital Management
Filed 2025-11-12
$12M
-13.8%
Goldman Sachs
Filed 2026-02-10
$8M
+11.4%
Charles Schwab
Filed 2025-11-10
$5M
+3.6%
Dark-pool activity snapshot
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.